Voya Financial Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,349
Closed -$372K 286
2021
Q1
$372K Buy
1,349
+57
+4% +$15.4K 0.01% 492
2020
Q4
$315K Sell
1,292
-17
-1% -$4.39K 0.01% 504
2020
Q3
$370K Sell
1,309
-30
-2% -$8.37K 0.02% 423
2020
Q2
$349K Buy
1,339
+28
+2% +$8.42K 0.02% 444
2020
Q1
$414K Sell
1,311
-104
-7% -$31.6K 0.02% 381
2019
Q4
$419K Buy
1,415
+34
+2% +$9.43K 0.02% 434
2019
Q3
$318K Sell
1,381
-268
-16% -$62.4K 0.02% 472
2019
Q2
$395K Sell
1,649
-277
-14% -$64K 0.02% 434
2019
Q1
$448K Buy
1,926
+204
+12% +$64.2K 0.03% 393
2018
Q4
$505K Buy
1,722
+283
+20% +$90.3K 0.03% 322
2018
Q3
$512K Buy
1,439
+350
+32% +$121K 0.03% 350
2018
Q2
$314K Buy
+1,089
New +$306K 0.02% 428

Other funds holding BIIB

Voya Financial Advisors's BIIB Position: Q2 2021 in Review

Voya Financial Advisors sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,349 shares — an estimated $372K sold.

Voya Financial Advisors first reported a position in BIIB in Q2 2018 and held it in 12 quarters. The position peaked at $512K in Q3 2018. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Voya Financial Advisors reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 1,349 Biogen shares in Q2 2021, an estimated $372K.
  • Voya Financial Advisors first reported a position in Biogen in Q2 2018 and held it in 12 quarters.
  • Voya Financial Advisors's Biogen position peaked at $512K in Q3 2018.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.